☰

Rebecca A. Larson, Ph.D. - Publications

Affiliations: 
2010 Michigan State University, East Lansing, MI 
Area:
Agricultural Engineering
Tree Info Similar researchers PubMed Report error

30/350 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Sanford JR, Aguirre-Villegas HA, Larson RA. Pork Production Survey to Assess Factors of Facility Design and Operation Sustainability. 12: 4536. DOI: 10.3390/Su12114536  0.324
2020 Sanford JR, Larson RA. Assessing Nitrogen Cycling in Corncob Biochar Amended Soil Columns for Application in Agricultural Treatment Systems Agronomy. 10: 979. DOI: 10.3390/Agronomy10070979  0.345
2020 Uddin ME, Larson RA, Wattiaux MA. Effects of dairy cow breed and dietary forage on greenhouse gas emissions from manure during storage and after field application Journal of Cleaner Production. 270: 122461. DOI: 10.1016/J.Jclepro.2020.122461  0.308
2019 Sanford JR, Larson RA. Treatment of horizontal silage bunker runoff using biochar amended vegetative filter strips. Journal of Environmental Management. 253: 109746. PMID 31666216 DOI: 10.1016/J.Jenvman.2019.109746  0.399
2019 Wang H, Larson RA, Borchardt M, Spencer S. Effect of Mixing Duration on Biogas Production and Methanogen Distribution in an Anaerobic Digester. Environmental Technology. 1-19. PMID 31159681 DOI: 10.1080/09593330.2019.1621951  0.319
2019 Walsh J, Sanford J, Larson R. Evaluation of Biochar Nitrate Extraction Methods Applied Sciences. 9: 3514. DOI: 10.3390/App9173514  0.302
2019 Wang H, Aguirre-Villegas HA, Larson RA, Alkan-Ozkaynak A. Physical Properties of Dairy Manure Pre- and Post-Anaerobic Digestion Applied Sciences. 9: 2703. DOI: 10.3390/App9132703  0.303
2019 Aguirre-Villegas HA, Larson RA, Sharara MA. Anaerobic digestion, solid-liquid separation, and drying of dairy manure: Measuring constituents and modeling emission Science of the Total Environment. 696: 134059. DOI: 10.1016/J.Scitotenv.2019.134059  0.346
2019 Kim D, Stoddart N, Rotz CA, Veltman K, Chase L, Cooper J, Ingraham P, Izaurralde RC, Jones CD, Gaillard R, Aguirre-Villegas HA, Larson RA, Ruark M, Salas W, Jolliet O, et al. Analysis of beneficial management practices to mitigate environmental impacts in dairy production systems around the Great Lakes Agricultural Systems. 176: 102660. DOI: 10.1016/J.Agsy.2019.102660  0.357
2018 Aguirre-Villegas HA, Sharara MA, Larson RA. Nutrient Variability Following Dairy Manure Storage Agitation Applied Engineering in Agriculture. 34: 908-917. DOI: 10.13031/Aea.12796  0.324
2018 Veltman K, Rotz CA, Chase L, Cooper J, Ingraham P, Izaurralde RC, Jones CD, Gaillard R, Larson RA, Ruark M, Salas W, Thoma G, Jolliet O. A quantitative assessment of Beneficial Management Practices to reduce carbon and reactive nitrogen footprints and phosphorus losses on dairy farms in the US Great Lakes region Agricultural Systems. 166: 10-25. DOI: 10.1016/J.Agsy.2018.07.005  0.358
2018 Holly MA, Larson RA, Cooley ET, Wunderlin AM. Silage storage runoff characterization: Annual nutrient loading rate and first flush analysis of bunker silos Agriculture, Ecosystems & Environment. 264: 85-93. DOI: 10.1016/J.Agee.2018.05.015  0.364
2017 Aguirre-Villegas HA, Passos-Fonseca TH, Reinemann DJ, Larson R. Got pasture? How grazing intensity affects the environmental impacts of dairy systems. Journal of Dairy Science. PMID 28601442 DOI: 10.3168/Jds.2016-12325  0.361
2017 McCord AI, Stefanos SA, Tumwesige V, Lsoto D, Meding AH, Adong A, Schauer JJ, Larson RA. The impact of biogas and fuelwood use on institutional kitchen air quality in Kampala, Uganda. Indoor Air. PMID 28423205 DOI: 10.1111/Ina.12390  0.316
2017 Sharara M, Sampat A, Good LW, Smith AS, Porter P, Zavala VM, Larson R, Runge T. Spatially explicit methodology for coordinated manure management in shared watersheds. Journal of Environmental Management. 192: 48-56. PMID 28135587 DOI: 10.1016/J.Jenvman.2017.01.033  0.356
2017 Yang Q, Wang H, Larson R, Runge TM. Comparative Study of Chemical Pretreatments of Dairy Manure for Enhanced Biomethane Production Bioresources. 12: 7363-7375. DOI: 10.15376/Biores.12.4.7363-7375  0.313
2017 Holly MA, Larson RA. Effects of Manure Storage Additives on Manure Composition and Greenhouse Gas and Ammonia Emissions Transactions of the Asabe. 60: 449-456. DOI: 10.13031/Trans.12066  0.33
2017 Aguirre-Villegas HA, Larson RA. Evaluating greenhouse gas emissions from dairy manure management practices using survey data and lifecycle tools Journal of Cleaner Production. 143: 169-179. DOI: 10.1016/J.Jclepro.2016.12.133  0.327
2017 Holly MA, Larson RA, Powell JM, Ruark MD, Aguirre-Villegas H. Greenhouse gas and ammonia emissions from digested and separated dairy manure during storage and after land application Agriculture, Ecosystems & Environment. 239: 410-419. DOI: 10.1016/J.Agee.2017.02.007  0.306
2017 Holly MA, Larson RA. Thermochemical Conversion of Biomass Storage Covers to Reduce Ammonia Emissions from Dairy Manure Water, Air, & Soil Pollution. 228. DOI: 10.1007/S11270-017-3588-X  0.345
2016 Sanford JR, Larson RA. Evaluation of Phosphorus Filter Media for an Inline Subsurface Drainage Treatment System. Journal of Environmental Quality. 45: 1919-1925. PMID 27898781 DOI: 10.2134/Jeq2016.01.0038  0.365
2016 Holly MA, Larson RA. Treatment of Silage Runoff Using Vegetated Filter Strips Transactions of the Asabe. 59: 1645-1650. DOI: 10.13031/Trans.59.11600  0.371
2015 Bradley A, Larson RA, Runge T. Effect of Wood Biochar in Manure-Applied Sand Columns on Leachate Quality. Journal of Environmental Quality. 44: 1720-1728. PMID 26641323 DOI: 10.2134/Jeq2015.04.0196  0.402
2015 Aguirre-Villegas HA, Passos-Fonseca TH, Reinemann DJ, Armentano LE, Wattiaux MA, Cabrera VE, Norman JM, Larson R. Green cheese: partial life cycle assessment of greenhouse gas emissions and energy intensity of integrated dairy production and bioenergy systems. Journal of Dairy Science. 98: 1571-92. PMID 25597974 DOI: 10.3168/Jds.2014-8850  0.34
2015 Vadas PA, Good LW, Panuska JC, Busch DL, Larson RA. A new model for phosphorus loss in runoff from outdoor cattle lots Transactions of the Asabe. 58: 1035-1045. DOI: 10.13031/Trans.58.11105  0.301
2015 Aguirre-Villegas HA, Larson R, Reinemann DJ. Effects of management and co-digestion on life cycle emissions and energy from anaerobic digestion Greenhouse Gases: Science and Technology. DOI: 10.1002/Ghg.1506  0.32
2014 Aguirre-Villegas HA, Larson R, Reinemann DJ. From waste-to-worth: Energy, emissions, and nutrient implications of manure processing pathways Biofuels, Bioproducts and Biorefining. 8: 770-793. DOI: 10.1002/Bbb.1496  0.303
2012 Larson RA, Safferman SI. Field application of farmstead runoff to vegetated filter strips: surface and subsurface water quality assessment. Journal of Environmental Quality. 41: 592-603. PMID 22370421 DOI: 10.2134/Jeq2011.0125  0.66
2011 Safferman SI, Fernandez-Torres I, Pfiffner SM, Larson RA, Mokma DL. Predicting the onset of metal leaching from land application of wastewater using soil sensors and microbial community analyses Journal of Environmental Engineering. 137: 97-107. DOI: 10.1061/(Asce)Ee.1943-7870.0000294  0.653
2009 Larson RA, Safferman SI. Aerobic treatment unit performance on milking parlor wash water Transactions of the Asabe. 52: 825-834. DOI: 10.13031/2013.27404  0.357
Low-probability matches (unlikely to be authored by this person)
2011 Larson RA, Safferman SI. Vegetative filter strips: Surface and subsurface water quality American Society of Agricultural and Biological Engineers Annual International Meeting 2011, Asabe 2011. 5: 3990-3998.  0.297
2020 Sharara MA, Owusu-Twum MY, Runge TM, Larson R. Planning methodology for anaerobic digestion systems on animal production facilities under uncertainty. Waste Management (New York, N.Y.). 104: 262-269. PMID 31991267 DOI: 10.1016/J.Wasman.2020.01.028  0.297
2019 Sanford JR, Larson RA, Runge T. Nitrate sorption to biochar following chemical oxidation. The Science of the Total Environment. 669: 938-947. PMID 30970460 DOI: 10.1016/J.Scitotenv.2019.03.061  0.296
2017 Burch TR, Spencer SK, Stokdyk JP, Kieke BA, Larson RA, Firnstahl AD, Rule AM, Borchardt MA. Quantitative Microbial Risk Assessment for Spray Irrigation of Dairy Manure Based on an Empirical Fate and Transport Model. Environmental Health Perspectives. 125: 087009. PMID 28885976 DOI: 10.1289/Ehp283  0.296
2019 Sampat AM, Hu Y, Sharara M, Aguirre-Villegas H, Ruiz-Mercado G, Larson RA, Zavala VM. Coordinated Management of Organic Waste and Derived Products. Computers & Chemical Engineering. 128: 352-363. PMID 32704194 DOI: 10.1016/J.Compchemeng.2019.06.008  0.294
2017 Shutske JM, Schaefer D, Larson R, Erb K, Skjolaas C, Leonard S, Nelson J, Binversie E, Rifleman S. Investigation of a worker death while agitating manure in a non-enclosed storage. Journal of Agromedicine. PMID 29068771 DOI: 10.1080/1059924X.2017.1397076  0.294
2008 Larson RA, Safferman SI. Storm water best management practices that maximize aquifer recharge Journal of Green Building. 3: 126-138. DOI: 10.3992/Jgb.3.1.126  0.288
2018 Burch TR, Spencer SK, Borchardt SS, Larson RA, Borchardt MA. Fate of Manure-Borne Pathogens during Anaerobic Digestion and Solids Separation. Journal of Environmental Quality. 47: 336-344. PMID 29634802 DOI: 10.2134/Jeq2017.07.0285  0.278
2018 Hu Y, Scarborough M, Aguirre-Villegas H, Larson RA, Noguera DR, Zavala VM. A Supply Chain Framework for the Analysis of the Recovery of Biogas and Fatty Acids from Organic Waste Acs Sustainable Chemistry & Engineering. 6: 6211-6222. DOI: 10.1021/Acssuschemeng.7B04932  0.278
2019 Aguirre-Villegas HA, Passos-Fonseca TH, Reinemann DJ, Larson R. Corrigendum to "Grazing intensity affects the environmental impact of dairy systems" (J. Dairy Sci. 100:6804-6821). Journal of Dairy Science. 102: 923-925. PMID 30583787 DOI: 10.3168/Jds.2019-102-1-0923  0.267
2017 Shutske JM, Larson RA, Schaefer DM, Binversie LY, Rifleman S, Skjolaas C. Notes from the Field: Death of a Farm Worker After Exposure to Manure Gas in an Open Air Environment - Wisconsin, August 2016. Mmwr. Morbidity and Mortality Weekly Report. 66: 861-862. PMID 28817555 DOI: 10.15585/Mmwr.Mm6632A6  0.264
2023 Romanko CA, Gay JD, Powell JM, Wattiaux M, Barford C, Larson RA, Ruark MD. Soil greenhouse gas flux and nitrogen mineralization following manure application from tannin-fed dairy cows. Journal of Environmental Quality. PMID 38054550 DOI: 10.1002/jeq2.20534  0.263
2018 Sharara MA, Runge T, Larson R, Primm JG. Techno-economic optimization of community-based manure processing Agricultural Systems. 161: 117-123. DOI: 10.1016/J.Agsy.2018.01.006  0.262
2019 McCord AI, Stefanos SA, Tumwesige V, Lsoto D, Kawala M, Mutebi J, Nansubuga I, Larson RA. Anaerobic digestion in Uganda: risks and opportunities for integration of waste management and agricultural systems Renewable Agriculture and Food Systems. 1-10. DOI: 10.1017/S1742170519000346  0.261
2024 Burns M, Tang H, Larson RA, Qin M. Bioelectrochemically-assisted ammonia recovery from dairy manure. Water Research. 252: 121243. PMID 38330718 DOI: 10.1016/j.watres.2024.121243  0.247
2009 Larson RA, Safferman SI. Storm water runoff characterization from animal feeding operations American Society of Agricultural and Biological Engineers Annual International Meeting 2009, Asabe 2009. 7: 4263-4273.  0.229
1940 Larson RA, Lucas PS. A Method for Calculating the Baumé Reading of Condensed Ice Cream Mixes Journal of Dairy Science. 23: 229-244. DOI: 10.3168/Jds.S0022-0302(40)95517-5  0.227
2023 Aguirre-Villegas HA, Besson C, Larson RA. Modeling ammonia emissions from manure in conventional, organic, and grazing dairy systems and practices to mitigate emissions. Journal of Dairy Science. PMID 37690730 DOI: 10.3168/jds.2023-23782  0.223
2015 Bradley A, Larson RA, Runge T. Impact of biochar additions to nitrogen leaching in sand columns American Society of Agricultural and Biological Engineers Annual International Meeting 2015. 5: 4122-4125.  0.217
2022 Burch T, Firnstahl AD, Spencer SK, Larson R, Borchardt M. Fate and seasonality of antimicrobial resistance genes during full-scale anaerobic digestion of cattle manure across seven livestock production facilities. Journal of Environmental Quality. PMID 35388483 DOI: 10.1002/jeq2.20350  0.181
2022 Feng X, Larson RA, Digman MF. Evaluating the Feasibility of a Low-Field Nuclear Magnetic Resonance (NMR) Sensor for Manure Nutrient Prediction. Sensors (Basel, Switzerland). 22. PMID 35408053 DOI: 10.3390/s22072438  0.173
1988 McGuire CF, Stallknecht GF, Larson RA. Impact of cropping systems on end-use quality of hard red spring wheat Field Crops Research. 18: 203-206. DOI: 10.1016/0378-4290(88)90010-X  0.168
2015 Romero IC, Schwing PT, Brooks GR, Larson RA, Hastings DW, Ellis G, Goddard EA, Hollander DJ. Hydrocarbons in Deep-Sea Sediments following the 2010 Deepwater Horizon Blowout in the Northeast Gulf of Mexico. Plos One. 10: e0128371. PMID 26020923 DOI: 10.1371/Journal.Pone.0128371  0.162
2015 Schwing PT, Romero IC, Brooks GR, Hastings DW, Larson RA, Hollander DJ. A decline in benthic foraminifera following the deepwater horizon event in the northeastern Gulf of Mexico. Plos One. 10: e0120565. PMID 25785988 DOI: 10.1371/Journal.Pone.0120565  0.161
1992 Larson RA, Stackhouse PL, Crowley TO. Riboflavin tetraacetate: A potentially useful photosensitizing agent for the treatment of contaminated waters Environmental Science and Technology. 26: 1792-1798.  0.157
1981 Larson RA, Smykowski K, Hunt LL. Occurrence and determination of organic oxidants in rivers and wastewaters Chemosphere. 10: 1335-1338. DOI: 10.1016/0045-6535(81)90052-7  0.148
1989 Larson RA, Ellis DD, Ju HL, Marley KA. Flavin-sensitized photodecomposition of anilines and phenols Environmental Toxicology and Chemistry. 8: 1165-1170.  0.142
1987 Wedeking CA, Snoeyink VL, Larson RA, Ding J. Wet air regeneration of PAC: Comparison of carbons with different surface oxygen characteristics Water Research. 21: 929-937. DOI: 10.1016/S0043-1354(87)80010-6  0.141
1991 Larson RA. Ferric ion promoted photodecomposition of triazines Journal of Agricultural and Food Chemistry®. 39: 2057-2062.  0.135
2015 Sanford JR, Larson RA. Evaluation of phosphorus filter media for an in-line tile drainage treatment system American Society of Agricultural and Biological Engineers Annual International Meeting 2015. 3: 2323-2328.  0.134
1988 Recktenwalt MA, Snoeyink VL, Larson RA. Sequential wet air regeneration of PAC from the powdered carbon-activated sludge process Journal of the Water Pollution Control Federation. 60: 1439-1444.  0.133
1986 Voudrias EA, Larson RA, Snoeyink VL, Chen AS, Stapleton PL. Hypochlorous acid-activated carbon: an oxidizing agent capable of producing hydroxylated polychlorinated biphenyls. Environmental Health Perspectives. 69: 97-100. PMID 3028770 DOI: 10.1289/Ehp.866997  0.13
2015 Wang H, Larson RA. Effect of dietary tannin on bio-methane potential of dairy manure American Society of Agricultural and Biological Engineers Annual International Meeting 2015. 3: 1870-1874.  0.121
2007 Cloyd RA, Dickinson A, Larson RA, Marley KA. Effect of growing media and their constituents on fungus gnat, bradysia sp. nr. coprophila (lintner) adults Insect Science. 14: 467-475. DOI: 10.1111/J.1744-7917.2007.00175.X  0.12
1986 Voudrias EA, Snoeyink VL, Larson RA. Desorption of organics formed on activated carbon Journal / American Water Works Association. 78: 82-86. DOI: 10.1002/J.1551-8833.1986.Tb05700.X  0.118
1985 Voudrias EA, Larson RA, Snoeyink VL. Effects of activated carbon on the reactions of free chlorine with phenols Environmental Science and Technology. 19: 441-449. DOI: 10.1021/Es00135A010  0.116
2015 Brooks GR, Larson RA, Schwing PT, Romero I, Moore C, Reichart GJ, Jilbert T, Chanton JP, Hastings DW, Overholt WA, Marks KP, Kostka JE, Holmes CW, Hollander D. Sedimentation Pulse in the NE Gulf of Mexico following the 2010 DWH Blowout. Plos One. 10: e0132341. PMID 26172639 DOI: 10.1371/Journal.Pone.0132341  0.116
2015 Holly MA, Larson RA, Powell JM. Gas reduction benefits from storage to application of anaerobic digestion and solid-liquid separation of dairy manure American Society of Agricultural and Biological Engineers Annual International Meeting 2015. 6: 4448-4460.  0.113
1994 Larson RA, Ellis DD, Galka C. Effects of additives on the formation of organochlorine compounds during the combustion of paper-ferric chloride mixtures Science of the Total Environment, The. 143: 261-268. DOI: 10.1016/0048-9697(94)90462-6  0.112
1996 Larson RA, Miller PL, Crowley TO. Borohydride photoreduction of nitroaromatic compounds related to military ordnance constituents Environmental Science and Technology. 30: 1192-1197. DOI: 10.1021/Es950415Y  0.109
1979 Larson RA, Bott TL, Hunt LL, Rogenmuser K. Photooxidation products of a fuel oil and their antimicrobial activity Environmental Science and Technology. 13: 965-969. DOI: 10.1021/es60156a011  0.109
1985 Voudrias EA, Larson RA, Snoeyink VL. Effects of activated carbon on the reactions of combined chlorine with phenols Water Research. 19: 909-915. DOI: 10.1016/0043-1354(85)90150-2  0.108
1977 Larson RA, Hunt LL, Blankenship DW. Formation of toxic products from a #2 fuel oil by photooxidation Environmental Science and Technology. 11: 492-496.  0.107
1984 Larson RA, Marley KA. Quenching of singlet oxygen by alkaloids and related nitrogen heterocycles Phytochemistry. 23: 2351-2354. DOI: 10.1016/S0031-9422(00)80550-6  0.106
1990 Larson RA, Garrison WJ, Carlson RW. Differential responses of alpine and non-alpine Aquilegia species to increased ultraviolet-B radiation Plant, Cell &Amp; Environment. 13: 983-987.  0.106
1994 DiNardo RC, Larson RA. Constituents of newsprint and municipal solid waste hydrolyzates Bioresource Technology. 48: 135-141. DOI: 10.1016/0960-8524(94)90200-3  0.105
1987 Voudrias EA, Larson RA, Snoeyink VL. Importance of surface free radicals in the reactivity of granular activated carbon under water treatment conditions Carbon. 25: 503-515. DOI: 10.1016/0008-6223(87)90191-6  0.104
1988 Berenbaum MR, Larson RA. Flux of singlet oxygen from leaves of phototoxic plants Experientia. 44: 1030-1032. DOI: 10.1007/BF01939914  0.104
2003 Hothem SD, Marley KA, Larson RA. Photochemistry in Hoagland's nutrient solution Journal of Plant Nutrition. 26: 845-854. DOI: 10.1081/PLN-120018569  0.103
2009 Larson RA, Palazotto AN, Gardenier HE. Impact response of titanium and titanium boride monolithic and functionally graded composite plates Aiaa Journal. 47: 676-691. DOI: 10.2514/1.38577  0.102
2005 Larson RA. Winning in diecutting Screen Printing. 95: 40-44.  0.1
1998 Dann EJ, Anastasi J, Larson RA. High-dose cladribine therapy for chronic myelogenous leukemia in the accelerated or blast phase Journal of Clinical Oncology. 16: 1498-1504. PMID 9552058 DOI: 10.1200/JCO.1998.16.4.1498  0.099
1978 Larson RA, Rockwell AL. Citric acid: Potential precursor of chloroform in water chlorination Naturwissenschaften. 65: 490. PMID 703851 DOI: 10.1007/BF00702843  0.099
1991 Chan WF, Larson RA. Mechanisms and products of ozonolysis of aniline in aqueous solution containing nitrite ion Water Research. 25: 1539-1544. DOI: 10.1016/0043-1354(91)90185-S  0.097
1990 Kaminer LS, Choi KE, Daley KM, Larson RA. Continuous infusion mitoxantrone in relapsed acute nonlymphocytic leukemia. Cancer. 65: 2619-23. PMID 2340463 DOI: 10.1002/1097-0142(19900615)65:12<2619::AID-CNCR2820651203>3.0.CO;2-I  0.096
1987 Jackson DE, Larson RA, Snoeyink VL. Reactions of chlorine and chlorine dioxide with resorcinol in aqueous solution and adsorbed on granular activated carbon Water Research. 21: 849-857. DOI: 10.1016/0043-1354(87)90162-X  0.096
1982 Chen ASC, Larson RA, Snoeyink VL. Reactions of chlorine dioxide with hydrocarbons: Effects of activated carbon Environmental Science and Technology. 16: 268-273.  0.095
1984 Chen ASC, Larson RA, Snoeyink VL. Importance of surface free radicals in an aqueous chlorination reaction (Indan-ClO2) promoted by granular activated carbon Carbon. 22: 63-75. DOI: 10.1016/0008-6223(84)90134-9  0.095
1978 Blankenship DW, Larson RA. Plant growth inhibition by the water extract of a crude oil Water, Air, and Soil Pollution. 10: 471-476. DOI: 10.1007/BF00250012  0.095
2012 Larson RA, Hochhaus A, Hughes TP, Clark RE, Etienne G, Kim DW, Flinn IW, Kurokawa M, Moiraghi B, Yu R, Blakesley RE, Gallagher NJ, Saglio G, Kantarjian HM. Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up. Leukemia. 26: 2197-203. PMID 22699418 DOI: 10.1038/leu.2012.134  0.095
1990 Hwang SC, Larson RA, Snoeyink VL. Reactions of free chlorine with substituted anilines in aqueous solution and on granular activated carbon Water Research. 24: 427-432. DOI: 10.1016/0043-1354(90)90224-T  0.095
2015 Larson RA. Is there a best TKI for chronic phase CML? Blood. 126: 2370-5. PMID 26585806 DOI: 10.1182/blood-2015-06-641043  0.094
2006 Larson RA. Myelodysplasia: When to treat and how Best Practice and Research: Clinical Haematology. 19: 293-300. PMID 16516126 DOI: 10.1016/j.beha.2005.11.005  0.093
2001 Cataland SR, Daugherty CK, Weseman EC, Larson RA. Preliminary experience with a new chemotherapy regimen for adults with acute lymphoblastic leukemia Leukemia and Lymphoma. 41: 297-307. PMID 11378542 DOI: 10.3109/10428190109057984  0.093
1995 Chan WF, Larson RA. Products of Ozonolysis of Aromatic Compounds in Aqueous Solution Containing Nitrite Ion Ozone: Science &Amp; Engineering. 17: 627-635. DOI: 10.1080/01919512.1995.10555774  0.092
2015 Conti RM, Padula WV, Larson RA. Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EU. Annals of Hematology. 94: S249-57. PMID 25814091 DOI: 10.1007/S00277-015-2319-X  0.092
2014 Hughes TP, Hochhaus A, Kantarjian HM, Cervantes F, Guilhot F, Niederwieser D, le Coutre PD, Rosti G, Ossenkoppele G, Lobo C, Shibayama H, Fan X, Menssen HD, Kemp C, Larson RA, et al. Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice daily. Haematologica. 99: 1204-11. PMID 24532039 DOI: 10.3324/haematol.2013.091272  0.091
1976 Larson RA, Weston JC. Analysis of water extracts of crude petroleum by gel permeation chromatography Bulletin of Environmental Contamination and Toxicology. 16: 44-52. PMID 963310 DOI: 10.1007/BF01753104  0.091
1982 Ellis DD, Jone CM, Larson RA, Schaeffer DJ. Organic constituents of mutagenic secondary effluents from wastewater treatment plants. Archives of Environmental Contamination and Toxicology. 11: 373-82. PMID 7103563 DOI: 10.1007/BF01055214  0.091
2014 Hughes TP, Saglio G, Kantarjian HM, Guilhot F, Niederwieser D, Rosti G, Nakaseko C, De Souza CA, Kalaycio ME, Meier S, Fan X, Menssen HD, Larson RA, Hochhaus A. Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib. Blood. 123: 1353-60. PMID 24335106 DOI: 10.1182/blood-2013-06-510396  0.089
2014 Rizzieri DA, Johnson JL, Byrd JC, Lozanski G, Blum KA, Powell BL, Shea TC, Nattam S, Hoke E, Cheson BD, Larson RA. Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002. British Journal of Haematology. 165: 102-11. PMID 24428673 DOI: 10.1111/bjh.12736  0.088
1982 Mears JA, Larson RA. Rubber and allergenic terpenes: possible problems in guayule commercialization Journal of Arid Environments. 5: 169-178.  0.088
1995 Slosson JE, Larson RA. Slope failures in southern California: rainfall threshold, prediction, and human causes Environmental &Amp; Engineering Geoscience. 1: 393-401.  0.088
1988 Larson RA, Marley KA. Sunlight photochlorination and dark chlorination of monoterpenes Science of the Total Environment, The. 77: 245-252. DOI: 10.1016/0048-9697(88)90060-5  0.087
1999 Finiewicz KJ, Larson RA. Dose-intensive therapy for adult acute lymphoblastic leukemia Seminars in Oncology. 26: 6-20. PMID 10073558  0.087
2014 Erba HP, Othus M, Walter RB, Kirschbaum MH, Tallman MS, Larson RA, Slovak ML, Kopecky KJ, Gundacker HM, Appelbaum FR. Four different regimens of farnesyltransferase inhibitor tipifarnib in older, untreated acute myeloid leukemia patients: North American Intergroup Phase II study SWOG S0432. Leukemia Research. 38: 329-33. PMID 24411921 DOI: 10.1016/J.Leukres.2013.12.001  0.087
2013 Baccarani M, Deininger MW, Rosti G, Hochhaus A, Soverini S, Apperley JF, Cervantes F, Clark RE, Cortes JE, Guilhot F, Hjorth-Hansen H, Hughes TP, Kantarjian HM, Kim DW, Larson RA, et al. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood. 122: 872-84. PMID 23803709 DOI: 10.1182/blood-2013-05-501569  0.086
2005 Kline JP, Larson RA. Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: A review Expert Opinion On Pharmacotherapy. 6: 2711-2718. PMID 16316309 DOI: 10.1517/14656566.6.15.2711  0.086
1985 Rippon JW, Arnow PM, Larson RA, Zang KL. Golden Tongue' Syndrome Caused by Ramichloridium schulzeri Archives of Dermatology. 121: 892-894. PMID 3860191 DOI: 10.1001/archderm.1985.01660070082020  0.086
1991 Chan WF, Larson RA. Formation of mutagens from the aqueous reactions of ozone and anilines Water Research. 25: 1529-1538. DOI: 10.1016/0043-1354(91)90184-R  0.086
1999 Toljanic JA, Bedard JF, Larson RA, Fox JP. A prospective pilot study to evaluate a new dental assessment and treatment paradigm for patients scheduled to undergo intensive chemotherapy for cancer Cancer. 85: 1843-1848. PMID 10223580 DOI: 10.1002/(SICI)1097-0142(19990415)85:8<1843::AID-CNCR26>3.0.CO;2-R  0.085
2012 Gardenier HE, Palazotto AN, Larson RA. Development and investigation of a slotted beam impact experiment for intermediate strain rates Journal of Aerospace Engineering. 25: 294-307. DOI: 10.1061/(Asce)As.1943-5525.0000112  0.085
2013 Petersdorf SH, Kopecky KJ, Slovak M, Willman C, Nevill T, Brandwein J, Larson RA, Erba HP, Stiff PJ, Stuart RK, Walter RB, Tallman MS, Stenke L, Appelbaum FR. A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia. Blood. 121: 4854-60. PMID 23591789 DOI: 10.1182/blood-2013-01-466706  0.085
2005 Larson RA, Mears MJ, Blue PA. Path planning for unmanned air vehicles to goal states in operational environments Collection of Technical Papers - Infotech At Aerospace: Advancing Contemporary Aerospace Technologies and Their Integration. 4: 2403-2414.  0.085
2013 Jabbour E, le Coutre PD, Cortes J, Giles F, Bhalla KN, Pinilla-Ibarz J, Larson RA, Gattermann N, Ottmann OG, Hochhaus A, Hughes TP, Saglio G, Radich JP, Kim DW, Martinelli G, et al. Prediction of outcomes in patients with Ph+ chronic myeloid leukemia in chronic phase treated with nilotinib after imatinib resistance/intolerance. Leukemia. 27: 907-13. PMID 23174881 DOI: 10.1038/Leu.2012.305  0.085
1994 Larson RA, Chuang FW. Thermal transformations of 1,4-dichlorobenzene: effects of temperature, time and presence of iron species Chemosphere. 29: 421-430. DOI: 10.1016/0045-6535(94)90116-3  0.085
1986 Larson RA. Insect defenses against phototoxic plant chemicals Journal of Chemical Ecology. 12: 859-870. DOI: 10.1007/BF01020256  0.085
2006 Cervini-Silva J, Larson RA, Stucki JW. Hydration/expansion and cation charge compensation modulate the Brønsted basicity of distorted clay water. Langmuir : the Acs Journal of Surfaces and Colloids. 22: 2961-5. PMID 16548541 DOI: 10.1021/La0602113  0.084
2006 Larson RA, Palazotto A. Low velocity impact analysis of functionally graded circular plates American Society of Mechanical Engineers, Aerospace Division (Publication) Ad. DOI: 10.1115/IMECE2006-14003  0.083
2015 Odenike O, Halpern A, Godley LA, Madzo J, Karrison T, Green M, Fulton N, Mattison RJ, Yee KW, Bennett M, Koval G, Malnassy G, Larson RA, Ratain MJ, Stock W. A phase I and pharmacodynamic study of the histone deacetylase inhibitor belinostat plus azacitidine in advanced myeloid neoplasia. Investigational New Drugs. 33: 371-9. PMID 25483416 DOI: 10.1007/S10637-014-0194-2  0.082
1994 Devine SM, Larson RA. Acute leukemia in adults: recent developments in diagnosis and treatment Ca-a Cancer Journal For Clinicians. 44: 326-352. PMID 7953914 DOI: 10.3322/CANJCLIN.44.6.326  0.081
1978 Callen DF, Larson RA. Toxic and genetic effects of fuel oil photoproducts and three hydroperoxides in saccharomyces cerevisiae Journal of Toxicology and Environmental Health. 4: 913-917. PMID 366161 DOI: 10.1080/15287397809529711  0.081
2003 Kebriaei P, Larson RA. Progress and challenges in the therapy of adult acute lymphoblastic leukemia Current Opinion in Hematology. 10: 284-289. PMID 12799534 DOI: 10.1097/00062752-200307000-00006  0.08
2001 Larson RA. Current use and future development of gemtuzumab ozogamicin Seminars in Hematology. 38: 24-31. PMID 11474494 DOI: 10.1016/S0037-1963(01)90153-2  0.079
2006 Kline J, Larson RA. Nelarabine in the treatment of refractory T-cell malignant diseases Expert Opinion On Pharmacotherapy. 7: 1791-1799. PMID 16925505 DOI: 10.1517/14656566.7.13.1791  0.079
2013 Jones JA, Ruppert AS, Zhao W, Lin TS, Rai K, Peterson B, Larson RA, Marcucci G, Heerema NA, Byrd JC. Patients with chronic lymphocytic leukemia with high-risk genomic features have inferior outcome on successive Cancer and Leukemia Group B trials with alemtuzumab consolidation: subgroup analysis from CALGB 19901 and CALGB 10101. Leukemia & Lymphoma. 54: 2654-9. PMID 23547837 DOI: 10.3109/10428194.2013.788179  0.078
2009 Larson RA, Palazotto AN. Property estimation in FGM plates subject to low-velocity impact loading Journal of Mechanics of Materials and Structures. 4: 1429-1451. DOI: 10.2140/Jomms.2009.4.1429  0.078
1994 Crowley TO, Larson RA. HPLC and GC Methods for Analysis of Water-Soluble Nitrosulfonic Acids Journal of Chromatographic Science. 32: 57-60. DOI: 10.1093/chromsci/32.2.57  0.078
2014 Schwing P, Romero I, Brooks G, Hastings D, Larson R, Hollander D. Characterizing the Deep Sea Benthic Foraminifera Impact and Response to the Deepwater Horizon Blowout in the Northeastern Gulf of Mexico International Oil Spill Conference Proceedings. 2014: 299744. DOI: 10.7901/2169-3358-2014-1-299744.1  0.078
2015 Voorhees PM, Orlowski RZ, Mulkey F, Watson P, Geyer S, Sanford BL, Bennett E, Chanan-Khan AA, Bloomfield CD, Larson RA. Long-term outcomes for newly-diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre phase II study. British Journal of Haematology. 171: 373-7. PMID 26202857 DOI: 10.1111/bjh.13592  0.078
2009 Mattison RJ, Larson RA. Role of allogeneic hematopoietic cell transplantation in adults with acute lymphoblastic leukemia Current Opinion in Oncology. 21: 601-608. PMID 19713843 DOI: 10.1097/CCO.0b013e32833156eb  0.077
1979 Larson RA, Rockwell AL. Chloroform and chlorophenol production by decarboxylation of natural acids during aqueous chlorination Environmental Science and Technology. 13: 325-329.  0.077
2004 Larson RA, Indu Rupassara S, Hothem SD. Green remediation of herbicides: Studies with atrazine Acs Symposium Series. 887: 129-139.  0.077
1997 Laport GF, Larson RA. Treatment of adult acute lymphoblastic leukemia Seminars in Oncology. 24: 70-82. PMID 9045306  0.077
1988 Larson RA, Marley KA, Tuveson RW, Berenbaum MR. β-Carboline alkaloids: Mechanisms of phototoxicity to bacteria and insects Photochem. Photobiol.. 48: 665-674. PMID 3071812 DOI: 10.1111/j.1751-1097.1988.tb02879.x  0.076
2014 Deininger MW, Kopecky KJ, Radich JP, Kamel-Reid S, Stock W, Paietta E, Emanuel PD, Tallman M, Wadleigh M, Larson RA, Lipton JH, Slovak ML, Appelbaum FR, Druker BJ. Imatinib 800 mg daily induces deeper molecular responses than imatinib 400 mg daily: results of SWOG S0325, an intergroup randomized PHASE II trial in newly diagnosed chronic phase chronic myeloid leukaemia. British Journal of Haematology. 164: 223-32. PMID 24383843 DOI: 10.1111/Bjh.12618  0.076
1996 Larson RA. Treatment of acute myeloid leukemia with antecedent myelodysplastic syndrome Leukemia. 10. PMID 8618465  0.076
2008 Godley LA, Larson RA. Therapy-related myeloid leukemia. Seminars in Oncology. 35: 418-29. PMID 18692692 DOI: 10.1053/J.Seminoncol.2008.04.012  0.076
2005 Larson RA, Bibel G. Experimental and analytical evaluation of buckling forces of a spiral wound flexible gasket American Society of Mechanical Engineers, Pressure Vessels and Piping Division (Publication) Pvp. 2: 97-104. DOI: 10.1115/PVP2005-71401  0.076
2007 Larson RA. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia? Best Practice and Research: Clinical Haematology. 20: 29-37. PMID 17336252 DOI: 10.1016/j.beha.2006.10.006  0.076
2009 Larson RA. Allogeneic hematopoietic cell transplantation is not recommended for all adults with standard-risk acute lymphoblastic leukemia in first complete remission Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 15: 11-16. PMID 19147070 DOI: 10.1016/j.bbmt.2008.11.018  0.076
2015 Lanasa MC, Andritsos L, Brown JR, Gabrilove J, Caligaris-Cappio F, Ghia P, Larson RA, Kipps TJ, Leblond V, Milligan DW, Janssens A, Johnson AJ, Heerema NA, Bühler A, Stilgenbauer S, et al. Final results of EFC6663: a multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia. Leukemia Research. 39: 495-500. PMID 25804339 DOI: 10.1016/J.Leukres.2015.02.001  0.076
1977 Larson RA. Environmental chemistry of reactive oxygen species C R C Critical Reviews in Environmental Control. 8: 197-246. DOI: 10.1080/10643387709381663  0.075
1991 Stock W, Larson RA. Neurocysticercosis coincident with acute myeloid leukemia: A case report Leukemia and Lymphoma. 4: 145-148. DOI: 10.3109/10428199109068058  0.075
1995 Tiong Ong S, Larson RA. Current management of acute lymphoblastic leukemia in adults Oncology. 9: 433-442. PMID 7547204  0.074
1988 Larson RA, Zepp RG. Environmental chemistry. Reactivity of the carbonate radical with aniline derivatives Environmental Toxicology and Chemistry. 7.  0.074
1997 Bell ML, Larson RA, Bailey DA. Vegetative growth responses of florist azaleas to Dikegulac, GA4+7, and 6-benzylamino purine Hortscience. 32: 690-693.  0.074
2006 Larson RA. Management of Acute Lymphoblastic Leukemia in Older Patients Seminars in Hematology. 43: 126-133. PMID 16616046 DOI: 10.1053/j.seminhematol.2006.01.007  0.074
1995 Chan WF, Larson RA. Formation of Azobenzenes and Azoxybenzenes from the Aqueous Reactions of Anilines and Ozone Ozone: Science &Amp; Engineering. 17: 619-625. DOI: 10.1080/01919512.1995.10555773  0.073
1985 McQueen KG, Larson RA. The occurrence of wittichenite and sulfide exsolution textures at the Glen deposit, Wee Jasper, New South Wales Neues Jahrbuch Fur Mineralogie, Monatshefte. 469-480.  0.073
2013 Li Z, Herold T, He C, Valk PJ, Chen P, Jurinovic V, Mansmann U, Radmacher MD, Maharry KS, Sun M, Yang X, Huang H, Jiang X, Sauerland MC, Büchner T, ... ... Larson RA, et al. Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 1172-81. PMID 23382473 DOI: 10.1200/Jco.2012.44.3184  0.072
2013 Hochhaus A, Saglio G, Larson RA, Kim DW, Etienne G, Rosti G, De Souza C, Kurokawa M, Kalaycio ME, Hoenekopp A, Fan X, Shou Y, Kantarjian HM, Hughes TP. Nilotinib is associated with a reduced incidence of BCR-ABL mutations vs imatinib in patients with newly diagnosed chronic myeloid leukemia in chronic phase. Blood. 121: 3703-8. PMID 23502220 DOI: 10.1182/blood-2012-04-423418  0.072
1993 Manfredo MJ, Larson RA. Managing for wildlife viewing recreation experiences - An application in Colorado Wildlife Society Bulletin. 21: 226-236.  0.071
1988 Hwang SC, Larson RA, Snoeyink VL. Organic bromine as a source of electrophilic bromine in aqueous chlorination reactions Chemosphere. 17: 1337-1342. DOI: 10.1016/0045-6535(88)90086-0  0.071
2015 Lucas DM, Ruppert AS, Lozanski G, Dewald GW, Lozanski A, Claus R, Plass C, Flinn IW, Neuberg DS, Paietta EM, Bennett JM, Jelinek DF, Gribben JG, Hussein MA, Appelbaum FR, ... Larson RA, et al. Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997. Leukemia & Lymphoma. 1-7. PMID 25721902 DOI: 10.3109/10428194.2015.1023800  0.071
2012 Lozanski G, Ruppert AS, Heerema NA, Lozanski A, Lucas DM, Gordon A, Gribben JG, Morrison VA, Rai KM, Marcucci G, Larson RA, Byrd JC. Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study. Leukemia & Lymphoma. 53: 1743-8. PMID 22369572 DOI: 10.3109/10428194.2012.668683  0.071
1993 Banaee J, Larson RA. Effects of additives on the formation of organochlorine compounds during the combustion of a chlorine-containing polymer Waste Management. 13: 77-82. DOI: 10.1016/0956-053X(93)90036-V  0.071
2013 Kantarjian HM, Larson RA, Cortés JE, Deering KL, Mauro MJ. Current practices in the management of chronic myeloid leukemia. Clinical Lymphoma, Myeloma & Leukemia. 13: 48-54. PMID 23103085 DOI: 10.1016/j.clml.2012.07.009  0.071
1988 Rippon JW, Larson RA, Rosenthal DM, Clayman J. Disseminated cutaneous and peritoneal hyalohyphomycosis caused by Fusarium species: Three cases and review of the literature Mycopathologia. 101: 105-111. PMID 3278237 DOI: 10.1007/BF00452895  0.07
2016 DeBoer R, Koval G, Mulkey F, Wetzler M, Devine S, Marcucci G, Stone RM, Larson RA, Bloomfield CD, Geyer S, Mullighan CG, Stock W. Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665. Leukemia & Lymphoma. 1-9. PMID 26892479 DOI: 10.3109/10428194.2016.1144881  0.07
1984 Pegues DA, Daly KM, Larson RA. Use of decline in D-xylose absorption to predict infection following intensive chemotherapy Cancer Treatment Reports. 68: 1489-1491. PMID 6509454  0.069
2012 Gallagher RE, Moser BK, Racevskis J, Poiré X, Bloomfield CD, Carroll AJ, Ketterling RP, Roulston D, Schachter-Tokarz E, Zhou DC, Chen IM, Harvey R, Koval G, Sher DA, Feusner JH, ... ... Larson RA, et al. Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia. Blood. 120: 2098-108. PMID 22734072 DOI: 10.1182/blood-2012-01-407601  0.068
2012 Wang ES, Lyons RM, Larson RA, Gandhi S, Liu D, Matei C, Scott B, Hu K, Yang AS. A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide. Journal of Hematology & Oncology. 5: 71. PMID 23190430 DOI: 10.1186/1756-8722-5-71  0.068
2007 Larson RA. Three New Drugs for Acute Lymphoblastic Leukemia: Nelarabine, Clofarabine, and Forodesine Seminars in Oncology. 34. PMID 18086342 DOI: 10.1053/j.seminoncol.2007.11.002  0.068
1982 Larson RA, Chung J, Scanu AM, Yachnin S. Neutrophils are required for the DNA synthetic response of human lymphocytes to mevalonic acid: Evidence suggesting that a nonsterol product of mevalonate is involved Proceedings of the National Academy of Sciences of the United States of America. 79: 3028-3032. PMID 6953445 DOI: 10.1073/PNAS.79.9.3028  0.068
2016 Alachkar H, Fulton N, Sanford B, Malnassy G, Mutonga M, Larson RA, Bloomfield CD, Marcucci G, Nakamura Y, Stock W. Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemia. The Pharmacogenomics Journal. PMID 27019981 DOI: 10.1038/tpj.2016.7  0.068
1969 Thomas WH, Larson RA, Wright HK, Cleveland JC. Analysis of 830 cases of rectal adenocarcinoma. 1. Progressively improved results of treatment Connecticut Medicine. 33: 569-570. PMID 5823555  0.068
1998 Larson RA, Fretzin MH, Dodge RK, Schiffer CA. Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia. Leukemia. 12: 660-5. PMID 9593262 DOI: 10.1038/Sj.Leu.2401007  0.067
2005 Larson RA, Le Beau MM. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans. Chemico-Biological Interactions. 153: 187-95. PMID 15935816 DOI: 10.1016/j.cbi.2005.03.023  0.067
1992 Asthana A, Larson RA, Marley KA, Tuveson RW. Mechanisms of citral phototoxicity Photochemistry and Photobiology. 56: 211-222. PMID 1502265  0.067
1993 Nucifora G, Larson RA, Rowley JD. Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission Blood. 82: 712-715. PMID 8338940  0.067
2014 Wetzler M, Mrózek K, Kohlschmidt J, Dombret H, Döhner H, Pilorge S, Krug U, Carroll AJ, Larson RA, Marcucci G, Hiddemann W, Büchner T, Bloomfield CD. Intensive induction is effective in selected octogenarian acute myeloid leukemia patients: prognostic significance of karyotype and selected molecular markers used in the European LeukemiaNet classification. Haematologica. 99: 308-13. PMID 24097631 DOI: 10.3324/Haematol.2013.092072  0.065
2014 Coutre SE, Othus M, Powell B, Willman CL, Stock W, Paietta E, Levitan D, Wetzler M, Attar EC, Altman JK, Gore SD, Maher T, Kopecky KJ, Tallman MS, Larson RA, et al. Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy. British Journal of Haematology. 165: 497-503. PMID 24528179 DOI: 10.1111/Bjh.12775  0.065
2007 Larson RA. Etiology and management of therapy-related myeloid leukemia Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 453-459. PMID 18024664 DOI: 10.1182/ASHEDUCATION-2007.1.453  0.065
2005 Larson RA. Acute lymphoblastic leukemia: older patients and newer drugs Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 131-136. PMID 16304370 DOI: 10.1182/ASHEDUCATION-2005.1.131  0.064
2012 Radich JP, Kopecky KJ, Appelbaum FR, Kamel-Reid S, Stock W, Malnassy G, Paietta E, Wadleigh M, Larson RA, Emanuel P, Tallman M, Lipton J, Turner AR, Deininger M, Druker BJ. A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemia. Blood. 120: 3898-905. PMID 22915637 DOI: 10.1182/Blood-2012-02-410688  0.064
2013 Churpek JE, Larson RA. The evolving challenge of therapy-related myeloid neoplasms. Best Practice & Research. Clinical Haematology. 26: 309-17. PMID 24507808 DOI: 10.1016/j.beha.2013.09.001  0.064
2011 Larson RA, Le Beau MM. Prognosis and therapy when acute promyelocytic leukemia and other "good risk" acute myeloid leukemias occur as a therapy-related myeloid neoplasm. Mediterranean Journal of Hematology and Infectious Diseases. 3: e2011032. PMID 21869918 DOI: 10.4084/MJHID.2011.032  0.063
2014 Poiré X, Moser BK, Gallagher RE, Laumann K, Bloomfield CD, Powell BL, Koval G, Gulati K, Holowka N, Larson RA, Tallman MS, Appelbaum FR, Sher D, Willman C, Paietta E, et al. Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype. Leukemia & Lymphoma. 55: 1523-32. PMID 24160850 DOI: 10.3109/10428194.2013.842985  0.063
2016 Tsai SB, Liu H, Shore T, Fan Y, Bishop M, Cushing MM, Gergis U, Godley L, Kline J, Larson RA, Martinez G, Mayer S, Odenike O, Stock W, Wickrema A, et al. Frequency and Risk Factors Associated with Cord Graft Failure (CGF) after Transplant with Single Unit Umbilical Cord Cells Supplemented by Haploidentical Cells (Haplo-Cord) with Reduced-Intensity Conditioning. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26912055 DOI: 10.1016/J.Bbmt.2016.02.010  0.063
1982 Larson RA, Ultmann JE. The strategic role of laparotomy in staging Hodgkin's disease Cancer Treatment Reports. 66: 767-774. PMID 7074647  0.063
2015 Othus M, Appelbaum FR, Petersdorf SH, Kopecky KJ, Slovak M, Nevill T, Brandwein J, Larson RA, Stiff PJ, Walter RB, Tallman MS, Stenke L, Erba HP. Fate of patients with newly diagnosed acute myeloid leukemia who fail primary induction therapy. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 559-64. PMID 25536215 DOI: 10.1016/J.Bbmt.2014.10.025  0.063
2006 Larson RA. Should therapy-related myeloid leukemia be treated like de novo acute myeloid leukemia? Haematologica Reports. 2: 66-70.  0.062
2008 Larson RA. Allogeneic hematopoietic cell transplantation for adults with ALL Bone Marrow Transplantation. 42. PMID 18724292 DOI: 10.1038/bmt.2008.107  0.062
2007 Cloyd RA, Dickinson A, Larson RA, Marley KA. Phototaxis of fungus gnat, Bradysia sp. nr coprophila (Lintner) (Diptera: Sciaridae), adults to different light intensities Hortscience. 42: 1217-1220.  0.061
1992 Preisler HD, Raza A, Larson RA. Alteration of the proliferative rate of acute myelogenous leukemia cells in vivo in patients Blood. 80: 2600-2603. PMID 1421377  0.061
2014 Jain N, Curran E, Iyengar NM, Diaz-Flores E, Kunnavakkam R, Popplewell L, Kirschbaum MH, Karrison T, Erba HP, Green M, Poire X, Koval G, Shannon K, Reddy PL, Joseph L, ... ... Larson RA, et al. Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 490-8. PMID 24178622 DOI: 10.1158/1078-0432.Ccr-13-1311  0.061
2012 Whitman SP, Caligiuri MA, Maharry K, Radmacher MD, Kohlschmidt J, Becker H, Mrózek K, Wu YZ, Schwind S, Metzeler KH, Mendler JH, Wen J, Baer MR, Powell BL, Carter TH, ... ... Larson RA, et al. The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia. Leukemia. 26: 1713-7. PMID 22382894 DOI: 10.1038/Leu.2012.34  0.061
2000 Larson RA. Recent clinical trials in acute lymphocytic leukemia by the cancer and leukemia group B Hematology/Oncology Clinics of North America. 14: 1367-1379. PMID 11147228 DOI: 10.1016/S0889-8588(05)70191-X  0.06
2012 Mrózek K, Marcucci G, Nicolet D, Maharry KS, Becker H, Whitman SP, Metzeler KH, Schwind S, Wu YZ, Kohlschmidt J, Pettenati MJ, Heerema NA, Block AW, Patil SR, Baer MR, ... ... Larson RA, et al. Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 4515-23. PMID 22987078 DOI: 10.1200/JCO.2012.43.4738  0.06
2016 Caceres S, Peña L, Lacerda L, Illera MJ, de Andres PJ, Larson RA, Gao H, Debeb BG, Woodward WA, Reuben JM, Illera JC. Canine cell line, IPC-366, as a good model for the study of inflammatory breast cancer. Veterinary and Comparative Oncology. PMID 27146723 DOI: 10.1111/Vco.12238  0.06
2014 Muffly LS, Kocherginsky M, Stock W, Chu Q, Bishop MR, Godley LA, Kline J, Liu H, Odenike OM, Larson RA, van Besien K, Artz AS. Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients. Haematologica. 99: 1373-9. PMID 24816237 DOI: 10.3324/Haematol.2014.103655  0.06
1979 Larson RA. AUTOCONDITIONING SYSTEM FOR BNL NEGATIVE ION SOURCES Proceedings of the Symposium On Engineering Problems of Fusion Research. 4: 2024-2026.  0.06
2015 Devine SM, Owzar K, Blum W, Mulkey F, Stone RM, Hsu JW, Champlin RE, Chen YB, Vij R, Slack J, Soiffer RJ, Larson RA, Shea TC, Hars V, Sibley AB, et al. Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26527780 DOI: 10.1200/Jco.2015.62.7273  0.06
2013 Lin RJ, Larson RA, van Besien K, Rich ES. Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Myeloid Leukemia following Orthotopic Cardiac Transplantation. Case Reports in Hematology. 2013: 140138. PMID 23607004 DOI: 10.1155/2013/140138  0.06
2013 Giles FJ, le Coutre PD, Pinilla-Ibarz J, Larson RA, Gattermann N, Ottmann OG, Hochhaus A, Radich JP, Saglio G, Hughes TP, Martinelli G, Kim DW, Novick S, Gillis K, Fan X, et al. Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study. Leukemia. 27: 107-12. PMID 22763385 DOI: 10.1038/Leu.2012.181  0.059
1991 Ferry J, Larson RA. A mixed solvent for rapid TLC analysis of phenolic compounds Journal of Chromatographic Science. 29: 476-477. DOI: 10.1093/Chromsci/29.11.476  0.058
2014 Beumer JH, Owzar K, Lewis LD, Jiang C, Holleran JL, Christner SM, Blum W, Devine S, Kolitz JE, Linker C, Vij R, Alyea EP, Larson RA, Ratain MJ, Egorin MJ. Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103). Cancer Chemotherapy and Pharmacology. 74: 927-38. PMID 25163570 DOI: 10.1007/S00280-014-2571-0  0.058
2010 Larson RA. Micro-RNAs and copy number changes: New levels of gene regulation in acute myeloid leukemia Chemico-Biological Interactions. 184: 21-25. PMID 19822134 DOI: 10.1016/j.cbi.2009.10.002  0.057
2016 Jiang X, Bugno J, Hu C, Yang Y, Herold T, Qi J, Chen P, Gurbuxani S, Arnovitz S, Strong J, Ferchen K, Ulrich B, Weng H, Wang Y, Huang H, ... ... LArson RA, et al. Eradication of acute myeloid leukemia with FLT3 ligand-targeted miR-150 nanoparticles. Cancer Research. PMID 27280396 DOI: 10.1158/0008-5472.Can-15-2949  0.057
2013 Schwind S, Edwards CG, Nicolet D, Mrózek K, Maharry K, Wu YZ, Paschka P, Eisfeld AK, Hoellerbauer P, Becker H, Metzeler KH, Curfman J, Kohlschmidt J, Prior TW, Kolitz JE, ... ... Larson RA, et al. inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations. Blood. 121: 385-91. PMID 23160462 DOI: 10.1182/Blood-2012-07-442772  0.057
2013 Attar EC, Johnson JL, Amrein PC, Lozanski G, Wadleigh M, DeAngelo DJ, Kolitz JE, Powell BL, Voorhees P, Wang ES, Blum W, Stone RM, Marcucci G, Bloomfield CD, Moser B, ... Larson RA, et al. Bortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 923-9. PMID 23129738 DOI: 10.1200/JCO.2012.45.2177  0.057
2009 Larson RA. Therapeutic monitoring of drug plasma concentrations and improved outcomes in CML Clinical Advances in Hematology and Oncology. 7: 3-5. PMID 19391309  0.057
1983 Larson RA, Gordon LI, Yachnin S. Neutrophil-assisted DNA synthesis by human lymphocytes in response to mevalonic acid; enhancement by cytochalasin B Cellular Immunology. 81: 357-372. PMID 6640672 DOI: 10.1016/0008-8749(83)90243-5  0.057
1988 Robertson MJ, Larson RA. Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapy The American Journal of Medicine. 84: 233-239. PMID 3407652 DOI: 10.1016/0002-9343(88)90419-6  0.057
2012 Yang H, Durocher JJ, Larson RA, Dellavalla JP, Carter JR. Total sleep deprivation alters cardiovascular reactivity to acute stressors in humans. Journal of Applied Physiology (Bethesda, Md. : 1985). 113: 903-8. PMID 22815387 DOI: 10.1152/japplphysiol.00561.2012  0.057
2014 McNerney ME, Brown CD, Peterson AL, Banerjee M, Larson RA, Anastasi J, Le Beau MM, White KP. The spectrum of somatic mutations in high-risk acute myeloid leukaemia with -7/del(7q). British Journal of Haematology. 166: 550-6. PMID 24931631 DOI: 10.1111/Bjh.12964  0.056
2014 Larson RA, Dethlefs RA, Searer GR. Case studies and practical examples related to facade access equipment Structures Congress 2014 - Proceedings of the 2014 Structures Congress. 1808-1823. DOI: 10.1061/9780784413357.160  0.056
2015 Niederwieser C, Kohlschmidt J, Volinia S, Whitman SP, Metzeler KH, Eisfeld AK, Maharry K, Yan P, Frankhouser D, Becker H, Schwind S, Carroll AJ, Nicolet D, Mendler JH, Curfman JP, ... ... Larson RA, et al. Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia. Leukemia. 29: 567-75. PMID 25204569 DOI: 10.1038/Leu.2014.267  0.056
1996 Ong ST, Koeppen H, Larson RA, Olopade OI. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with fludarabine [1] Blood. 88: 2354-2355. PMID 8822958  0.056
1978 Larson RA, Stabler PP. Sensitized photooxidation of nitrilotriacetic and iminodiacetic acids Journal of Environmental Science and Health. Part a: Environmental Science and Engineering. 13: 545-552. DOI: 10.1080/10934527809374833  0.056
1984 Larson RA, Yachnin S. Mevalonic acid induces DNA synthesis in chronic lymphocytic leukemia cells Blood. 64: 257-262. PMID 6610447  0.056
2015 DiPersio JF, Erba HP, Larson RA, Luger SM, Tallman MS, Brill JM, Vuagniaux G, Rouits E, Sorensen JM, Zanna C. Oral Debio1143 (AT406), an Antagonist of Inhibitor of Apoptosis Proteins, Combined With Daunorubicin and Cytarabine in Patients With Poor-Risk Acute Myeloid Leukemia-Results of a Phase I Dose-Escalation Study. Clinical Lymphoma, Myeloma & Leukemia. 15: 443-9. PMID 25842225 DOI: 10.1016/j.clml.2015.02.020  0.056
2012 Claus R, Lucas DM, Stilgenbauer S, Ruppert AS, Yu L, Zucknick M, Mertens D, Bühler A, Oakes CC, Larson RA, Kay NE, Jelinek DF, Kipps TJ, Rassenti LZ, Gribben JG, et al. Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 2483-91. PMID 22564988 DOI: 10.1200/Jco.2011.39.3090  0.056
2015 Schwing PT, Romero IC, Brooks GR, Hastings DW, Larson RA, Hollander DJ. Correction: A Decline in Benthic Foraminifera following the Deepwater Horizon Event in the Northeastern Gulf of Mexico. Plos One. 10: e0128505. PMID 25992680 DOI: 10.1371/journal.pone.0128505  0.056
2012 Marcucci G, Metzeler KH, Schwind S, Becker H, Maharry K, Mrózek K, Radmacher MD, Kohlschmidt J, Nicolet D, Whitman SP, Wu YZ, Powell BL, Carter TH, Kolitz JE, Wetzler M, ... ... Larson RA, et al. Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 742-50. PMID 22291079 DOI: 10.1200/Jco.2011.39.2092  0.055
2015 D'Angelo CR, Kocherginsky M, Pisano J, Bishop MR, Godley LA, Kline J, Larson RA, Liu H, Odenike O, Stock W, Artz AS. Incidence and predictors of respiratory viral infections by multiplex PCR in allogeneic hematopoietic cell transplant recipients 50 years and older including geriatric assessment. Leukemia & Lymphoma. 1-7. PMID 26699199 DOI: 10.3109/10428194.2015.1113279  0.055
2013 Stock W, Johnson JL, Stone RM, Kolitz JE, Powell BL, Wetzler M, Westervelt P, Marcucci G, DeAngelo DJ, Vardiman JW, McDonnell D, Mrózek K, Bloomfield CD, Larson RA. Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia: results of Cancer and Leukemia Group B Study 19802. Cancer. 119: 90-8. PMID 22744771 DOI: 10.1002/Cncr.27617  0.054
1991 Hohl RJ, Larson RA, Mannickarottu V, Yachnin S. Inhibition of hydroxymethylglutaryl coenzyme A reductase activity induces a paradoxical increase in DNA synthesis in myeloid leukemia cells Blood. 77: 1064-1070. PMID 1995091 DOI: 10.1182/Blood.V77.5.1064.Bloodjournal7751064  0.054
1993 Spielberger RT, Stock W, Larson RA. Listeriosis after 2-chlorodeoxyadenosine treatment [4] New England Journal of Medicine. 328: 813-814. PMID 8094890 DOI: 10.1056/NEJM199303183281117  0.054
2012 Gui L, LaGrange LP, Larson RA, Gu M, Zhu J, Chen QH. Role of small conductance calcium-activated potassium channels expressed in PVN in regulating sympathetic nerve activity and arterial blood pressure in rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 303: R301-10. PMID 22647293 DOI: 10.1152/ajpregu.00114.2012  0.054
1983 Hoffman PC, Richman CM, Larson RA, Yachnin S. Cholesterol and mevalonic acid are independent requirements for the in vitro proliferation of human bone marrow granulocyte progenitor cells: studies using ML-236B. Blood. 61: 667-71. PMID 6831033  0.053
2016 Padula WV, Larson RA, Dusetzina SB, Apperley JF, Hehlmann R, Baccarani M, Eigendorff E, Guilhot J, Guilhot F, Hehlmann R, Mahon FX, Martinelli G, Mayer J, Müller MC, Niederwieser D, et al. Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States. Journal of the National Cancer Institute. 108. PMID 26944912 DOI: 10.1093/Jnci/Djw003  0.053
1981 Larson RA, Golomb HM, Rowley JD. Chromosome changes in hematologic malignancies Ca-a Cancer Journal For Clinicians. 31: 222-238. PMID 6796217 DOI: 10.3322/CANJCLIN.31.4.222  0.052
1975 Larson RA, Weston JC, Howell SM. Quantitative gas chromatographic determination of nitrilotriacetic acid in the presence of other carboxylic acids Journal of Chromatography A. 111: 43-49. PMID 1159005 DOI: 10.1016/S0021-9673(01)80144-8  0.052
2005 Larson RA, Pachter M, Mears MJ. Path planning by unmanned air vehicles for engaging an integrated radar network Collection of Technical Papers - Aiaa Guidance, Navigation, and Control Conference. 5: 3540-3555.  0.051
2016 Rojek K, Nickels E, Neistadt B, Marquez R, Wickrema A, Artz A, van Besien K, Larson RA, Lee MK, Segal JP, King MC, Walsh T, Shimamura A, Keel SB, Churpek JE, et al. Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27497531 DOI: 10.1016/j.bbmt.2016.08.002  0.051
2016 Madan V, Shyamsunder P, Han L, Mayakonda A, Nagata Y, Sundaresan J, Kanojia D, Yoshida K, Ganesan S, Hattori N, Fulton N, Tan KT, Alpermann T, Kuo MC, Rostami S, ... ... Larson RA, et al. Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia. Leukemia. PMID 27063598 DOI: 10.1038/leu.2016.69  0.051
1997 Dann EJ, Daugherty CK, Larson RA. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma Bone Marrow Transplantation. 20: 369-374. PMID 9339751  0.051
2014 Kolitz JE, George SL, Benson DM, Maharry K, Marcucci G, Vij R, Powell BL, Allen SL, Deangelo DJ, Shea TC, Stock W, Bakan CE, Hars V, Hoke E, Bloomfield CD, ... ... Larson RA, et al. Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808. Cancer. 120: 1010-7. PMID 24382782 DOI: 10.1002/Cncr.28516  0.051
2013 Jain N, Liu H, Artz AS, Anastasi J, Odenike O, Godley LA, Joseph L, Marino S, Kline J, Nguyen V, Schouten V, Kunnavakkam R, Larson RA, Stock W, Ulaszek J, et al. Immune reconstitution after combined haploidentical and umbilical cord blood transplant. Leukemia & Lymphoma. 54: 1242-9. PMID 23088744 DOI: 10.3109/10428194.2012.739688  0.051
1984 Larson RA, Kluskens LE, Yachnin S. The DNA synthetic response of normal and abnormal human lymphocytes to mevalonic acid: The role of granulocytes as a helper population The Journal of Allergy and Clinical Immunology. 74: 280-290. PMID 6236250 DOI: 10.1016/0091-6749(84)90259-8  0.05
2013 Solh M, Rai KR, Peterson BL, Kolitz JE, Appelbaum FR, Tallman MS, Belch A, Larson RA, Morrison VA. The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011). Leukemia & Lymphoma. 54: 252-4. PMID 22897733 DOI: 10.3109/10428194.2012.710327  0.05
1988 Tuveson RW, Larson RA, Kagan J. Role of cloned carotenoid genes expressed in Escherichia coli in protecting against inactivation by near-UV light and specific phototoxic molecules. Journal of Bacteriology. 170: 4675-80. PMID 3049544  0.049
1992 Larson RA, Lloyd RE, Marley KA, Tuveson RW. Ferric-ion-photosensitized damage to DNA by hydroxyl and non-hydroxyl radical mechanisms Journal of Photochemistry and Photobiology, B: Biology. 14: 345-357. PMID 1403376 DOI: 10.1016/1011-1344(92)85113-9  0.049
2002 Kebriaei P, Anastasi J, Larson RA. Acute lymphoblastic leukaemia: Diagnosis and classification Best Practice and Research: Clinical Haematology. 15: 597-621. PMID 12617866 DOI: 10.1053/beha.2002.0224  0.049
2013 Woods WG, Franklin AR, Alonzo TA, Gerbing RB, Donohue KA, Othus M, Horan J, Appelbaum FR, Estey EH, Bloomfield CD, Larson RA. Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trials. Cancer. 119: 4170-9. PMID 24104597 DOI: 10.1002/Cncr.28344  0.048
2015 Topp MS, Gökbuget N, Stein AS, Zugmaier G, O'Brien S, Bargou RC, Dombret H, Fielding AK, Heffner L, Larson RA, Neumann S, Foà R, Litzow M, Ribera JM, Rambaldi A, et al. Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study. The Lancet. Oncology. 16: 57-66. PMID 25524800 DOI: 10.1016/S1470-2045(14)71170-2  0.048
2013 Burgeson JR, Moore AL, Gharaibeh DN, Larson RA, Cerruti NR, Amberg SM, Hruby DE, Dai D. Discovery and optimization of potent broad-spectrum arenavirus inhibitors derived from benzimidazole and related heterocycles Bioorganic and Medicinal Chemistry Letters. 23: 750-756. PMID 23265900 DOI: 10.1016/j.bmcl.2012.11.093  0.047
1983 Yachnin S, Larson RA, West EJ. Rates of cholesterol biosynthesis are related to early differentiation in acute non-lymphocytic leukaemia cells British Journal of Haematology. 54: 459-466. PMID 6574789  0.047
2012 Giacobbi PR, Dietrich F, Larson R, White LJ. Exercise and quality of life in women with multiple sclerosis. Adapted Physical Activity Quarterly : Apaq. 29: 224-42. PMID 22811564 DOI: 10.1123/Apaq.29.3.224  0.047
2000 Cervini-Silva J, Wu J, Larson RA, Stucki JW. Transformation of chloropicrin in the presence of iron-bearing clay minerals Acs Division of Environmental Chemistry, Preprints. 40: 190-191.  0.047
2021 Trombetta BA, Kandigian SE, Kitchen RR, Grauwet K, Webb PK, Miller GA, Jennings CG, Jain S, Miller S, Kuo Y, Sweeney T, Gilboa T, Norman M, Simmons DP, Ramirez CE, ... ... Larson R, et al. Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2. Bmc Infectious Diseases. 21: 580. PMID 34134647 DOI: 10.1186/s12879-021-06257-7  0.047
2013 Dai D, Burgeson JR, Gharaibeh DN, Moore AL, Larson RA, Cerruti NR, Amberg SM, Bolken TC, Hruby DE. Discovery and optimization of potent broad-spectrum arenavirus inhibitors derived from benzimidazole. Bioorganic & Medicinal Chemistry Letters. 23: 744-9. PMID 23265895 DOI: 10.1016/j.bmcl.2012.11.095  0.046
1977 Larson RA. ELECTRONICS SYSTEM FOR THE 150 kV NEGATIVE ION TEST STAND AT BNL . 1: 377-381.  0.046
2018 Roy S, Hansen AR, Ross L, Larson R. A Qualitative Study to Assess Barber Perceptions of the Feasibility of the Employer as a Health Advisor for Obesity Prevention. American Journal of Men's Health. 1557988318768586. PMID 29658399 DOI: 10.1177/1557988318768586  0.045
2015 Castillo JJ, Mulkey F, Geyer S, Kolitz JE, Blum W, Powell BL, George SL, Larson RA, Stone RM. Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (Alliance) clinical trials. American Journal of Hematology. PMID 26526191 DOI: 10.1002/ajh.24230  0.045
2012 Jiang X, Huang H, Li Z, He C, Li Y, Chen P, Gurbuxani S, Arnovitz S, Hong GM, Price C, Ren H, Kunjamma RB, Neilly MB, Salat J, Wunderlich M, ... ... Larson RA, et al. MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia. Proceedings of the National Academy of Sciences of the United States of America. 109: 19397-402. PMID 23132946 DOI: 10.1073/Pnas.1217519109  0.045
1988 Larson RA. The antioxidants of higher plants Phytochemistry. 27: 969-978. DOI: 10.1016/0031-9422(88)80254-1  0.045
2014 von Keudell G, Larson RA. Positron Emission Tomography-Computed Tomography Imaging of a Patient With Several Myeloid Sarcomas With FLT3-ITD and NPM1 Mutations. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 24733791 DOI: 10.1200/JCO.2013.50.0140  0.045
1983 Larson RA, Yachnin S. Cytochalasin B is a potent mitogen for chronic lymphocytic leukemia cells in vitro Journal of Clinical Investigation. 72: 1268-1276. PMID 6630510 DOI: 10.1172/JCI111083  0.045
1986 Fattore L, Larson RA, Mostofi RS. Dental management of cancer patients receiving chemotherapy Imj. Illinois Medical Journal. 169: 223-227. PMID 2870997  0.044
2016 Kantarjian HM, Stein AS, Bargou RC, Grande Garcia C, Larson RA, Stelljes M, Gökbuget N, Zugmaier G, Benjamin JE, Zhang A, Jia C, Topp MS. Blinatumomab treatment of older adults with relapsed/refractory B-precursor acute lymphoblastic leukemia: Results from two phase 2 studies. Cancer. PMID 27143254 DOI: 10.1002/cncr.30031  0.044
2013 Locke F, Agarwal R, Kunnavakkam R, van Besien K, Larson RA, Odenike O, Godley LA, Liu H, Le Beau MM, Gurbuxani S, Thirman MJ, Sipkins D, White C, Artz A, Stock W. A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes. Bone Marrow Transplantation. 48: 1437-43. PMID 23771005 DOI: 10.1038/Bmt.2013.79  0.044
2006 Le Beau MM, Larson RA. Therapy-related myeloid leukemia. A model for leukemogenesis Haematologica Reports. 2: 11-17.  0.044
2014 Jasielec JK, Larson RA. Management of Therapy-Related Myeloid Neoplasms Cancer Consult: Expertise For Clinical Practice. 120-125. DOI: 10.1002/9781118589199.ch17  0.044
2013 Woyach JA, Ruppert AS, Rai K, Lin TS, Geyer S, Kolitz J, Appelbaum FR, Tallman MS, Belch AR, Morrison VA, Larson RA, Byrd JC. Impact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of sequential cancer and leukemia group B studies. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 440-7. PMID 23233702 DOI: 10.1200/JCO.2011.41.5646  0.044
1997 Schiffer CA, Dodge R, Larson RA. Long-term follow-up of Cancer and Leukemia Group B studies in acute myeloid leukemia. Cancer. 80: 2210-4. PMID 9395036 DOI: 10.1002/(SICI)1097-0142(19971201)80:11+<2210::AID-CNCR8>3.0.CO;2-L  0.044
2012 Raca G, Larson RA. Acute myeloid leukemia: the challenge of unfavorable cytogenetics. Oncology (Williston Park, N.Y.). 26: 724, 726-7. PMID 22957405  0.044
1996 Thirman MJ, Larson RA. Therapy-related myeloid leukemia Hematology/Oncology Clinics of North America. 10: 293-320. PMID 8707757 DOI: 10.1016/S0889-8588(05)70340-3  0.044
2014 Zabriskie MS, Eide CA, Tantravahi SK, Vellore NA, Estrada J, Nicolini FE, Khoury HJ, Larson RA, Konopleva M, Cortes JE, Kantarjian H, Jabbour EJ, Kornblau SM, Lipton JH, Rea D, et al. BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia. Cancer Cell. 26: 428-42. PMID 25132497 DOI: 10.1016/J.Ccr.2014.07.006  0.044
1977 Larson RA, Rockwell AL. Gas chromatographic identification of some chlorinated aromatic acids, chlorophenols, and their aromatic acid precursors Journal of Chromatography A. 139: 186-190. DOI: 10.1016/S0021-9673(01)84142-X  0.043
2014 Wetzler M, Watson D, Stock W, Koval G, Mulkey FA, Hoke EE, McCarty JM, Blum WG, Powell BL, Marcucci G, Bloomfield CD, Linker CA, Larson RA. Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance). Haematologica. 99: 111-5. PMID 24077846 DOI: 10.3324/Haematol.2013.085811  0.043
2014 Greim H, Kaden DA, Larson RA, Palermo CM, Rice JM, Ross D, Snyder R. The bone marrow niche, stem cells, and leukemia: impact of drugs, chemicals, and the environment. Annals of the New York Academy of Sciences. 1310: 7-31. PMID 24495159 DOI: 10.1111/nyas.12362  0.043
2015 Yang H, Durocher JJ, Larson RA, Carter JR. Role of the ovarian cycle on neural cardiovascular control in sleep-deprived women. Journal of Applied Physiology (Bethesda, Md. : 1985). 118: 419-26. PMID 25539931 DOI: 10.1152/japplphysiol.00626.2014  0.043
1988 Daiter S, Larson RA, Weddington WW, Ultmann JE. Psychosocial symptomatology, personal growth, and development among young adult patients following the diagnosis of leukemia or lymphoma Journal of Clinical Oncology. 6: 613-617. PMID 3357005 DOI: 10.1200/JCO.1988.6.4.613  0.043
2013 Burgeson JR, Gharaibeh DN, Moore AL, Larson RA, Amberg SM, Bolken TC, Hruby DE, Dai D. Lead optimization of an acylhydrazone scaffold possessing antiviral activity against Lassa virus Bioorganic and Medicinal Chemistry Letters. 23: 5840-5843. PMID 24064500 DOI: 10.1016/j.bmcl.2013.08.103  0.042
2004 Pachter M, Chandler PR, Larson RA, Purvis KB. Concepts for Generating Coherent Radar Phantom Tracks Using Cooperating Vehicles Collection of Technical Papers - Aiaa Guidance, Navigation, and Control Conference. 4: 2891-2904.  0.042
2000 Larson RA, Cervini-Silva J. Dechlorination of substituted trichloromethanes by an iron(II) porphyrin Environmental Toxicology and Chemistry. 19: 543-548.  0.042
2014 Ross AJ, Yang H, Larson RA, Carter JR. Sleep efficiency and nocturnal hemodynamic dipping in young, normotensive adults. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 307: R888-92. PMID 25031228 DOI: 10.1152/ajpregu.00211.2014  0.041
2011 Larson RA. CML: Live long and prosper Blood. 118: 4499-4500. PMID 22033940 DOI: 10.1182/blood-2011-08-369017  0.041
1993 Spielberger RT, Falleroni MJ, Coene AJ, Larson RA. Concomitant amphotericin b therapy, granulocyte transfusions, and gm-csf administration for disseminated infection with fusarium in a granulocytopenic patient Clinical Infectious Diseases. 16: 528-530. PMID 8513060 DOI: 10.1093/clind/16.4.528  0.041
2015 Gilmartin HM, Larson R. Improving school immunization rates may be as basic as record reconciliation and policy enforcement: a report from a rural Colorado public health/school district initiative. Journal of Public Health Management and Practice : Jphmp. 21: 269-72. PMID 25548987 DOI: 10.1097/PHH.0000000000000196  0.041
1969 Larson RA, Cleveland JC. Control of abdominal wall digestion after ileostomy breakdown — A complication of obesity: Report of a case Diseases of the Colon &Amp; Rectum. 12: 176-178. PMID 4238676 DOI: 10.1007/BF02617806  0.04
2014 Mirza MK, Sukhanova M, Stölzel F, Onel K, Larson RA, Stock W, Ehninger G, Kuithan F, Zöphel K, Reddy P, Joseph L, Raca G. Genomic aberrations in myeloid sarcoma without blood or bone marrow involvement: characterization of formalin-fixed paraffin-embedded samples by chromosomal microarrays. Leukemia Research. 38: 1091-6. PMID 25088808 DOI: 10.1016/J.Leukres.2014.05.004  0.04
2012 Mendler JH, Maharry K, Radmacher MD, Mrózek K, Becker H, Metzeler KH, Schwind S, Whitman SP, Khalife J, Kohlschmidt J, Nicolet D, Powell BL, Carter TH, Wetzler M, Moore JO, ... ... Larson RA, et al. RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 3109-18. PMID 22753902 DOI: 10.1200/Jco.2011.40.6652  0.039
2012 Li Z, Huang H, Li Y, Jiang X, Chen P, Arnovitz S, Radmacher MD, Maharry K, Elkahloun A, Yang X, He C, He M, Zhang Z, Dohner K, Neilly MB, ... ... Larson RA, et al. Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML. Blood. 119: 2314-24. PMID 22251480 DOI: 10.1182/Blood-2011-10-386235  0.039
2015 Churpek JE, Marquez R, Neistadt B, Claussen K, Lee MK, Churpek MM, Huo D, Weiner H, Bannerjee M, Godley LA, Le Beau MM, Pritchard CC, Walsh T, King MC, Olopade OI, ... Larson RA, et al. Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia. Cancer. PMID 26641009 DOI: 10.1002/Cncr.29615  0.039
2020 Freitas EDS, Miller RM, Heishman AD, Aniceto RR, Larson R, Pereira HM, Bemben D, Bemben MG. The perceptual responses of individuals with multiple sclerosis to blood flow restriction versus traditional resistance exercise. Physiology & Behavior. 113219. PMID 33250152 DOI: 10.1016/j.physbeh.2020.113219  0.038
2016 Mullane KM, Nuss C, Ridgeway J, Prichard MN, Hartline CB, Theusch J, Mommeja-Marin H, Larson RA. Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host. Transplant Infectious Disease : An Official Journal of the Transplantation Society. PMID 27481400 DOI: 10.1111/tid.12583  0.038
2012 Kutny MA, Moser BK, Laumann K, Feusner JH, Gamis A, Gregory J, Larson RA, Powell BL, Stock W, Willman CL, Woods WG, Meshinchi S. FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group. Pediatric Blood & Cancer. 59: 662-7. PMID 22378655 DOI: 10.1002/pbc.24122  0.038
1985 Larson RA. Management of myelodysplastic syndromes Annals of Internal Medicine. 103: 136-138. PMID 4003970 DOI: 10.7326/0003-4819-103-1-136  0.037
1990 Platanias LC, Larson RA, Anastasi J, Golomb HM. Relapse of hodgkin's disease after 14 years of complete remission Leukemia and Lymphoma. 3: 223-226. DOI: 10.3109/10428199009051000  0.037
2016 Larson RA, Carter JR. Total sleep deprivation and pain perception during cold noxious stimuli in humans Scandinavian Journal of Pain. 13: 12-16. DOI: 10.1016/j.sjpain.2016.05.037  0.037
2016 Debeb BG, Lacerda L, Anfossi S, Diagaradjane P, Chu K, Bambhroliya A, Huo L, Wei C, Larson RA, Wolfe AR, Xu W, Smith DL, Li L, Ivan C, Allen PK, et al. miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer. Journal of the National Cancer Institute. 108. PMID 27075851 DOI: 10.1093/Jnci/Djw026  0.037
2012 Richa EM, Kunnavakkam R, Godley LA, Kline J, Odenike O, Larson RA, Nguyen V, Stock W, Wickrema A, Van Besien K, Artz AS. Influence of related donor age on outcomes after peripheral blood stem cell transplantation. Cytotherapy. 14: 707-15. PMID 22548695 DOI: 10.3109/14653249.2012.681041  0.037
2014 Wang X, Owzar K, Gupta P, Larson RA, Mulkey F, Miller AA, Lewis LD, Hurd D, Vij R, Ratain MJ, Murry DJ. Vatalanib population pharmacokinetics in patients with myelodysplastic syndrome: CALGB 10105 (Alliance). British Journal of Clinical Pharmacology. 78: 1005-13. PMID 24838014 DOI: 10.1111/Bcp.12427  0.037
2021 Trombetta BA, Kandigian SE, Kitchen RR, Grauwet K, Webb PK, Miller GA, Jennings CG, Jain S, Miller S, Kuo Y, Sweeney T, Gilboa T, Norman M, Simmons DP, Ramirez CE, ... ... Larson R, et al. Correction to: Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2. Bmc Infectious Diseases. 21: 628. PMID 34210278 DOI: 10.1186/s12879-021-06333-y  0.036
2000 Larson RA. Patients' willingness to pay for pharmaceutical care Journal of the American Pharmaceutical Association (Washington,D.C. : 1996). 40: 618-624. PMID 11029842  0.036
2022 Leick MB, Silva H, Scarfò I, Larson R, Choi BD, Bouffard AA, Gallagher K, Schmidts A, Bailey SR, Kann MC, Jan M, Wehrli M, Grauwet K, Horick N, Frigault MJ, et al. Non-cleavable hinge enhances avidity and expansion of CAR-T cells for acute myeloid leukemia. Cancer Cell. PMID 35452603 DOI: 10.1016/j.ccell.2022.04.001  0.036
1995 Somani J, Larson RA. Reimmunization after allogeneic bone marrow transplantation. The American Journal of Medicine. 98: 389-98. PMID 7709953 DOI: 10.1016/S0002-9343(99)80319-2  0.035
1991 Geller RB, Larson RA. Therapy for acute myeloid leukemia and acute lymphoblastic leukemia in adults Current Opinion in Oncology. 3: 30-38. PMID 2043696 DOI: 10.1097/00001622-199102000-00005  0.035
2012 Kamińska EC, Larson RA, Petronic-Rosic V. Amelanocytic anhidrotic alopecia areata-like phenotype after allogeneic hematopoietic cell transplant. Archives of Dermatology. 148: 931-4. PMID 22911189 DOI: 10.1001/archdermatol.2012.335  0.035
1985 Larson RA, Gaynor ER, Shepard KV, Daly KM. High-dose Ara-C plus VM-26 in adult acute lymphoblastic leukemia European Journal of Cancer and Clinical Oncology. 21: 1261-1263. PMID 3865776 DOI: 10.1016/0277-5379(85)90024-0  0.035
2015 Tefferi A, Kantarjian H, Rajkumar SV, Baker LH, Abkowitz JL, Adamson JW, Advani RH, Allison J, Antman KH, Bast RC, Bennett JM, Benz EJ, Berliner N, Bertino J, Bhatia R, ... ... Larson RA, et al. In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clinic Proceedings. 90: 996-1000. PMID 26211600 DOI: 10.1016/j.mayocp.2015.06.001  0.035
2012 Muffly L, Larson RA. Improving outcomes in childhood T-cell acute lymphoblastic leukemia: promising results from the Children's Oncology Group incorporating nelarabine into front-line therapy. Translational Pediatrics. 1: 120-2. PMID 26835275 DOI: 10.3978/j.issn.2224-4336.2012.09.03  0.034
2012 Eisfeld AK, Marcucci G, Maharry K, Schwind S, Radmacher MD, Nicolet D, Becker H, Mrózek K, Whitman SP, Metzeler KH, Mendler JH, Wu YZ, Liyanarachchi S, Patel R, Baer MR, ... ... Larson RA, et al. miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia. Blood. 120: 249-58. PMID 22529287 DOI: 10.1182/Blood-2012-02-408492  0.034
2012 Carter JR, Durocher JJ, Larson RA, DellaValla JP, Yang H. Sympathetic neural responses to 24-hour sleep deprivation in humans: sex differences. American Journal of Physiology. Heart and Circulatory Physiology. 302: H1991-7. PMID 22408018 DOI: 10.1152/ajpheart.01132.2011  0.034
1981 Larson RA, Sweet DL, Golomb HM. Response to 5-azacytidine in patients with refractory acute nonlymphocytic leukemia and association with chromosome findings Clinical Research. 29.  0.034
2015 Larson RA. Leukemia, acute lymphoblastic in adults (ALL) The 5-Minute Clinical Consult Standard 2016: Twenty Fourth Edition.  0.033
2002 Larson RA, Solomon J, Carpenter JP. Stent graft repair of visceral artery aneurysms Journal of Vascular Surgery. 36: 1260-1263. PMID 12469060 DOI: 10.1067/mva.2002.129645  0.033
1992 Schiffer CA, Larson RA, Bloomfield CD. Cancer and Leukemia Group B (CALGB) studies in adult acute lymhocytic leukemia. Leukemia. 6: 171-4. PMID 1578925  0.033
2013 Ottmann OG, Larson RA, Kantarjian HM, le Coutre PD, Baccarani M, Hochhaus A, Kim DW, Fan X, Novick S, Giles FJ. Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome--positive acute lymphoblastic leukemia. Leukemia. 27: 1411-3. PMID 23138184 DOI: 10.1038/leu.2012.324  0.033
2014 Chapp AD, Gui L, Huber MJ, Liu J, Larson RA, Zhu J, Carter JR, Chen QH. Sympathoexcitation and pressor responses induced by ethanol in the central nucleus of amygdala involves activation of NMDA receptors in rats. American Journal of Physiology. Heart and Circulatory Physiology. 307: H701-9. PMID 24993048 DOI: 10.1152/ajpheart.00005.2014  0.032
2009 Rosenbaum CA, Larson RA, Meyer RM. Acute Myeloid Leukemia in Adults: Remission Induction Therapy Evidence-Based Hematology. 268-277. DOI: 10.1002/9781444300857.ch33  0.032
2012 Yin OQ, Giles FJ, Baccarani M, le Coutre P, Chiparus O, Gallagher N, Saglio G, Hughes TP, Hochhaus A, Kantarjian HM, Larson RA. Concurrent use of proton pump inhibitors or H2 blockers did not adversely affect nilotinib efficacy in patients with chronic myeloid leukemia. Cancer Chemotherapy and Pharmacology. 70: 345-50. PMID 22623211 DOI: 10.1007/s00280-012-1881-3  0.031
1986 Larson RA, Garrison WJ, Marley KA. Preparation and photoisomerization of 2-formylcinnamaldehyde in solution Tetrahedron Letters. 27: 3987-3990. DOI: 10.1016/S0040-4039(00)84891-1  0.031
2021 Peterson JA, Chesbro G, Larson R, Larson D, Black CD. Short-Term Analysis (8 Weeks) of Social Distancing and Isolation on Mental Health and Physical Activity Behavior During COVID-19. Frontiers in Psychology. 12: 652086. PMID 33815233 DOI: 10.3389/fpsyg.2021.652086  0.031
2015 Li Z, Chen P, Su R, Li Y, Hu C, Wang Y, Arnovitz S, He M, Gurbuxani S, Zuo Z, Elkahloun AG, Li S, Weng H, Huang H, Neilly MB, ... ... Larson RA, et al. Overexpression and knockout of miR-126 both promote leukemogenesis through targeting distinct gene signaling. Blood. PMID 26361793 DOI: 10.1182/Blood-2015-04-639062  0.031
2013 Chen P, Price C, Li Z, Li Y, Cao D, Wiley A, He C, Gurbuxani S, Kunjamma RB, Huang H, Jiang X, Arnovitz S, Xu M, Hong GM, Elkahloun AG, ... ... Larson RA, et al. miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia. Proceedings of the National Academy of Sciences of the United States of America. 110: 11511-6. PMID 23798388 DOI: 10.1073/Pnas.1310144110  0.031
2009 Rosenbaum CA, Larson RA, Meyer RM. Acute Myeloid Leukemia in Adults: Postremission Therapy Evidence-Based Hematology. 278-286. DOI: 10.1002/9781444300857.ch34  0.031
2003 Larson RA. Is modulation of multidrug resistance a viable strategy for acute myeloid leukemia? Leukemia. 17: 488-491. PMID 12646935 DOI: 10.1038/sj.leu.2402809  0.03
2015 Larson RA, Gui L, Huber MJ, Chapp AD, Zhu J, LaGrange LP, Shan Z, Chen QH. Sympathoexcitation in ANG II-salt hypertension involves reduced SK channel function in the hypothalamic paraventricular nucleus. American Journal of Physiology. Heart and Circulatory Physiology. 308: H1547-55. PMID 25862832 DOI: 10.1152/ajpheart.00832.2014  0.029
2021 Matos S, Sturm B, Buhnerkempe M, Larson R, Wilson M. Risk Factors for Infection After Minor Dermatologic Procedures: A Case-Control Study. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. PMID 34417389 DOI: 10.1097/DSS.0000000000003163  0.027
1995 Chuang FW, Larson RA, Wessman MS. Zero-valent iron-promoted dechlorination of polychlorinated biphenyls Environmental Science &Amp; Technology. 2460-2463.  0.026
2014 Jasielec JK, Larson RA. Dasatinib-Related Pulmonary Toxicity Mimicking an Atypical Infection. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 24958829 DOI: 10.1200/JCO.2013.50.1981  0.026
2016 Hochhaus A, Saglio G, Hughes TP, Larson RA, Kim DW, Issaragrisil S, le Coutre PD, Etienne G, Dorlhiac-Llacer PE, Clark RE, Flinn IW, Nakamae H, Donohue B, Deng W, Dalal D, et al. Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial. Leukemia. PMID 26837842 DOI: 10.1038/Leu.2016.5  0.025
1993 Lloyd RE, Larson RA, Adair TL, Tuveson RW. Cu(II) sensitizes pBR322 plasmid DNA to inactivation by UV-B (280-315 nm) Photochemistry and Photobiology. 57: 1011-1017. PMID 8367530  0.025
2001 Larson RA. New agents for induction and postremission therapy of acute myeloid leukemia Leukemia. 15: 675-676. PMID 11368378 DOI: 10.1038/sj/leu/2402064  0.025
2016 Jiang X, Hu C, Arnovitz S, Bugno J, Yu M, Zuo Z, Chen P, Huang H, Ulrich B, Gurbuxani S, Weng H, Strong J, Wang Y, Li Y, Salat J, ... ... Larson RA, et al. miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia. Nature Communications. 7: 11452. PMID 27116251 DOI: 10.1038/Ncomms11452  0.024
2004 Larson RA. The U.S. trials in adult acute lymphoblastic leukemia Annals of Hematology. 83. PMID 15124704  0.024
2012 Schneider JE, Larson RA, Hill TD. Overview of the C-12J external stores flight test program 28th Aiaa Aerodynamic Measurement Technology, Ground Testing, and Flight Testing Conference 2012.  0.023
2001 Kantarjlan HM, Hoelzer D, Larson RA. Hematology/Oncology Clinics of North - America: Preface Hematology/Oncology Clinics of North America. 15.  0.023
2012 Jiang X, Huang H, Li Z, Li Y, Wang X, Gurbuxani S, Chen P, He C, You D, Zhang S, Wang J, Arnovitz S, Elkahloun A, Price C, Hong GM, ... ... Larson RA, et al. Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia. Cancer Cell. 22: 524-35. PMID 23079661 DOI: 10.1016/J.Ccr.2012.08.028  0.023
1992 Barton K, Larson RA, O'Brien S, Ratain MJ. Rapid response of B-cell prolymphocytic leukemia to 2- chlorodeoxyadenosine [4] Journal of Clinical Oncology. 10: 1821. PMID 1357112 DOI: 10.1200/JCO.1992.10.11.1821  0.023
1985 Kotake AN, Vogelzang NJ, Larson RA, Choporis N. New high-performance liquid chromatographic assay for plasma doxorubicin Journal of Chromatography B: Biomedical Sciences and Applications. 337: 194-200. PMID 3980653 DOI: 10.1016/0378-4347(85)80030-X  0.022
1968 Larson RA, Thomas H, Cleveland JC. Errors in management of head and neck tumors Ca: a Cancer Journal For Clinicians. 18: 92-95. PMID 4967702 DOI: 10.3322/canjclin.18.2.92  0.021
2009 Mattison R, Larson RA. Discontinuing imatinib in chronic myeloid leukemia: Don't try this at home Leukemia and Lymphoma. 50: 868-870. PMID 19455466 DOI: 10.1080/10428190902934951  0.021
2013 Gupta P, Mulkey F, Hasserjian RP, Sanford BL, Vij R, Hurd DD, Odenike OM, Bloomfield CD, Owzar K, Stone RM, Larson RA. A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance). Investigational New Drugs. 31: 1311-20. PMID 23700288 DOI: 10.1007/S10637-013-9978-Z  0.019
2012 Larson RA. Cytogenetics, not just previous therapy, determines the course of therapy-related myeloid neoplasms. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 2300-2. PMID 22585693 DOI: 10.1200/JCO.2011.41.1215  0.019
2015 Li Z, Stölzel F, Onel K, Sukhanova M, Mirza MK, Yap KL, Borinets O, Larson RA, Stock W, Sasaki MM, Joseph L, Raca G. Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma. Leukemia. PMID 25787914 DOI: 10.1038/Leu.2015.81  0.018
1969 Thomas WH, Larson RA, Wright HK, Cleveland JC. Analysis of 830 patients with rectal adenocarcinoma Surgery Gynecology and Obstetrics. 129: 10-14. PMID 4182972  0.018
1999 Lee MY, Jensen E, Kwak S, Larson RA. Metastatic adenocarcinoma arising in a congenital foregut cyst of the esophagus: A case report with review of the literature American Journal of Dermatopathology. 21: 64-66. DOI: 10.1097/00000421-199802000-00014  0.017
2022 Peach A, Blaise B, Parker J, Larson R. Noninflammatory presentation of cutaneous breast cancer: a retrospective case series at a single academic institution with review of the literature. Dermatology Online Journal. 28. PMID 36259855 DOI: 10.5070/D328458515  0.017
2004 Larson RA. Adult ALL: where are we and where are we going? Clinical Advances in Hematology &Amp; Oncology : H&Amp;O. 2: 342-344. PMID 16163203  0.016
2015 Larson RA. Is there a best TKI for chronic phase CML? Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2015: 250-6. PMID 26637730 DOI: 10.1182/asheducation-2015.1.250  0.016
2000 Larson RA. Myeloid leukemia after cytotoxic therapy and other hematotoxins Journal of Toxicology and Environmental Health - Part A. 61: 381-386. PMID 11086943 DOI: 10.1080/00984100050166398  0.015
2009 Larson RA. Therapy-related myeloid neoplasms Haematologica. 94: 454-459. PMID 19336749 DOI: 10.3324/haematol.2008.005157  0.015
2012 Ravandi F, Estey EH, Appelbaum FR, Lo-Coco F, Schiffer CA, Larson RA, Burnett AK, Kantarjian HM. Gemtuzumab ozogamicin: time to resurrect? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 3921-3. PMID 22987091 DOI: 10.1200/JCO.2012.43.0132  0.014
1972 Mabry TJ, Kimler L, Larson RA. Betalmic acid Hoppe-Seyler's Zeitschrift Fur Physiologische Chemie. 353: 127-128. PMID 5027688  0.014
1987 Frankel DH, Larson RA, Lorincz AL. Acral Lividosis—A Sign of Myeloproliferative Diseases: Hyperleukocytosis Syndrome in Chronic Myelogenous Leukemia Archives of Dermatology. 123: 921-924. PMID 3475043 DOI: 10.1001/archderm.1987.01660310089021  0.013
2020 Matos S, Wilson M, Larson R. Unilateral Septic Emboli From an Infected Pseudoaneurysm. Jama Dermatology. PMID 32074251 DOI: 10.1001/jamadermatol.2019.4927  0.01
2015 Larson RA. Myelodysplastic syndromes The 5-Minute Clinical Consult Standard 2016: Twenty Fourth Edition.  0.01
2012 Larson RA, Yin OQP. Author reply to Fujimi et al European Journal of Clinical Pharmacology. 68: 1573-1574. DOI: 10.1007/s00228-012-1276-8  0.01
2007 Gupta G, Larson RA, Jampol LM. Chronic lymphocytic leukemia masquerading as uveitis Retina. 27: 1311-1312. PMID 18046244 DOI: 10.1097/IAE.0b013e3180ca9b0e  0.01
2007 Samara MA, Brennan JM, Van Besien K, Larson RA. Cardiac tamponade in a patient with chronic lymphocytic leukemia. Leukemia & Lymphoma. 48: 829-32. PMID 17454648 DOI: 10.1080/10428190601142849  0.01
1989 Williams SF, Larson RA. Hypersensitivity reaction to high-dose cytarabine British Journal of Haematology. 73: 274-275. PMID 2530999 DOI: 10.1111/j.1365-2141.1989.tb00267.x  0.01
1970 Rinehart KL, Leadbetter G, Larson RA, Forbis RM. Nybomycin. III. A revised structure [22] Journal of the American Chemical Society. 92: 6994-6995.  0.01
1968 Thomas WH, Larson RA, Wright HK, Cleveland JC. An analysis of patients with carcinoma of the right colon Surgery Gynecology and Obstetrics. 127: 313-318. PMID 5662852  0.01
1965 Larson RA. A regulated, pulsed current system for focussing magnets Ieee Transactions On Nuclear Science. 327-333. DOI: 10.1109/TNS.1965.4323645  0.01
Hide low-probability matches.